Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Quorum sensing: dynamic response of Pseudomonas aeruginosa to external signals.

Wagner VE, Frelinger JG, Barth RK, Iglewski BH.

Trends Microbiol. 2006 Feb;14(2):55-8. Epub 2006 Jan 6.

PMID:
16406629
2.

Sensitivity to bleomycin-induced lung injury is not moderated by an antigen-limited T-cell repertoire.

Thatcher TH, Sime PJ, Barth RK.

Exp Lung Res. 2005 Sep;31(7):685-700.

PMID:
16203623
3.

Keratinocyte-derived, CD80-mediated costimulation is associated with hapten-specific IgE production during contact hypersensitivity to TH1 haptens.

Burns R, Luzina I, Nasir A, Haidaris CG, Barth RK, Gaspari AA.

J Allergy Clin Immunol. 2005 Feb;115(2):383-90.

PMID:
15696100
4.

A new murine model of humoral immuno-deficiency specifically affects class switching to T-independent antigens.

Kuzin II, Ugine GD, Barth RK, Shultz LD, Nahm MH, Young FM, Bottaro A.

Eur J Immunol. 2004 Jul;34(7):1807-16.

5.

Mapping susceptibility genes for the induction of pulmonary fibrosis in mice.

Barth RK, Hanchett LA, Baecher-Allan CM.

Chest. 2002 Mar;121(3 Suppl):21S. No abstract available.

PMID:
11893659
6.
7.
8.

The Roman god Janus: a paradigm for the function of CD43.

Ostberg JR, Barth RK, Frelinger JG.

Immunol Today. 1998 Dec;19(12):546-50. Review. No abstract available.

PMID:
9864944
9.

Regulation of human prostate-specific antigen gene expression in transgenic mice: evidence for an enhancer between the PSA and human glandular kallikrein-1 genes.

Wei C, Callahan BP, Turner MJ, Willis RA, Lord EM, Barth RK, Frelinger JG.

Int J Mol Med. 1998 Oct;2(4):487-96.

PMID:
9857240
10.

A transgenic strategy for analyzing the regulatory regions of the human prostate-specific antigen gene: potential applications for the treatment of prostate cancer (Review).

Willis RA, Wei C, Turner MJ, Callahan BP, Pugh AE, Barth RK, Lord EM, Frelinger JG.

Int J Mol Med. 1998 Feb;1(2):379-86. Review.

PMID:
9852240
11.
12.

Cell-specific gene expression reveals changes in epithelial cell populations after bleomycin treatment.

Daly HE, Baecher-Allan CM, Paxhia AT, Ryan RM, Barth RK, Finkelstein JN.

Lab Invest. 1998 Apr;78(4):393-400.

PMID:
9564884
13.

Characterization of the altered cutaneous reactivity of transgenic mice whose keratinocytes overexpress B7-1.

Gaspari AA, Burns RP Jr, Kondo S, Nasir A, Kurup A, Mlodynia D, Sauder D, Barth RK.

Clin Immunol Immunopathol. 1998 Mar;86(3):259-70.

PMID:
9557159
14.

Molecular analysis of skewed Tcra-V gene use in T-cell receptor beta-chain transgenic mice.

Burns RP Jr, Natarajan K, LoCascio NJ, O'Brien DP, Kobori JA, Shastri N, Barth RK.

Immunogenetics. 1998;47(2):107-14.

PMID:
9396856
15.

Expression of mouse CD43 in the B cell lineage of transgenic mice causes impaired immune responses to T-independent antigens.

Ostberg JR, Dragone LL, Borrello MA, Phipps RP, Barth RK, Frelinger JG.

Eur J Immunol. 1997 Sep;27(9):2152-9.

PMID:
9341753
16.

Elimination of T-cell-receptor beta-chain diversity in transgenic mice restricts antigen-specific but not alloreactive responses.

O'Brien DP, Baecher-Allan CM, Burns RP Jr, Shastri N, Barth RK.

Immunology. 1997 Jul;91(3):375-82.

17.

Tissue-specific expression of the human prostate-specific antigen gene in transgenic mice: implications for tolerance and immunotherapy.

Wei C, Willis RA, Tilton BR, Looney RJ, Lord EM, Barth RK, Frelinger JG.

Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6369-74.

19.

Bleomycin induces strain-dependent alterations in the pattern of epithelial cell-specific marker expression in mouse lung.

Daly HE, Baecher-Allan CM, Barth RK, D'Angio CT, Finkelstein JN.

Toxicol Appl Pharmacol. 1997 Feb;142(2):303-10.

PMID:
9070353
20.

Disregulated expression of CD43 (leukosialin, sialophorin) in the B cell lineage leads to immunodeficiency.

Ostberg JR, Dragone LL, Driskell T, Moynihan JA, Phipps R, Barth RK, Frelinger JG.

J Immunol. 1996 Dec 1;157(11):4876-84.

PMID:
8943391
21.

Expression of human prostate-specific antigen (PSA) in a mouse tumor cell line reduces tumorigenicity and elicits PSA-specific cytotoxic T lymphocytes.

Wei C, Storozynsky E, McAdam AJ, Yeh KY, Tilton BR, Willis RA, Barth RK, Looney RJ, Lord EM, Frelinger JG.

Cancer Immunol Immunother. 1996 Jul;42(6):362-8.

PMID:
8830740
22.

Fibroblast heterogeneity in the healing wound.

Sempowski GD, Borrello MA, Blieden TM, Barth RK, Phipps RP.

Wound Repair Regen. 1995 Apr-Jun;3(2):120-31.

PMID:
17173641
23.

Disregulation of leukosialin (CD43, Ly48, sialophorin) expression in the B-cell lineage of transgenic mice increases splenic B-cell number and survival.

Dragone LL, Barth RK, Sitar KL, Disbrow GL, Frelinger JG.

Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):626-30.

24.
25.
26.

Differential epitope expression of Ly-48 (mouse leukosialin).

Baecher-Allan CM, Kemp JD, Dorfman KS, Barth RK, Frelinger JG.

Immunogenetics. 1993;37(3):183-92.

PMID:
7678405
27.

Restriction fragment length polymorphisms of the mouse T-cell receptor gene families.

Klotz JL, Barth RK, Kiser GL, Hood LE, Kronenberg M.

Immunogenetics. 1989;29(3):191-201. Erratum in: Immunogenetics 1989;30(3):235.

PMID:
2564371
28.

Structure, organization and polymorphism of murine and human T-cell receptor alpha and beta chain gene families.

Wilson RK, Lai E, Concannon P, Barth RK, Hood LE.

Immunol Rev. 1988 Jan;101:149-72. Review. No abstract available.

PMID:
2965094
29.

Genomic organization of the mouse T-cell receptor beta-chain gene family.

Lai E, Barth RK, Hood L.

Proc Natl Acad Sci U S A. 1987 Jun;84(11):3846-50.

30.

The murine T-cell receptor uses a limited repertoire of expressed V beta gene segments.

Barth RK, Kim BS, Lan NC, Hunkapiller T, Sobieck N, Winoto A, Gershenfeld H, Okada C, Hansburg D, Weissman IL, et al.

Nature. 1985 Aug 8-14;316(6028):517-23.

PMID:
2412120
31.
32.

Detection of c-sis transcripts and synthesis of PDGF-like proteins by human osteosarcoma cells.

Graves DT, Owen AJ, Barth RK, Tempst P, Winoto A, Fors L, Hood LE, Antoniades HN.

Science. 1984 Nov 23;226(4677):972-4.

PMID:
6209798
33.
34.
35.

Developmentally regulated mRNAs in mouse liver.

Barth RK, Gross KW, Gremke LC, Hastie ND.

Proc Natl Acad Sci U S A. 1982 Jan;79(2):500-4.

Supplemental Content

Loading ...
Support Center